Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet Formulation
The bioequivalence of bempedoic acid oral suspension and commercial immediate release (IR) tablet formulations were assessed using a physiologically based pharmacokinetic (PBPK) model. The mechanistic model, developed from clinical mass balance results and in vitro intrinsic solubility, permeability...
Saved in:
Main Authors: | Benny M. Amore (Author), Nikunjkumar Patel (Author), Priya Batheja (Author), Ian E. Templeton (Author), Hannah M. Jones (Author), Michael J. Louie (Author), Maurice G. Emery (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of bempedoic acid in patients with renal impairment
by: Benny M. Amore, et al.
Published: (2022) -
Absence of effect of steady state bempedoic acid on cardiac repolarization: Results of a thorough QT/QTc study in healthy volunteers
by: Benny M. Amore, et al.
Published: (2021) -
Bempedoic Acid in Secondary Prevention
by: Idine Mousavi, et al.
Published: (2024) -
Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020) -
The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023)